Quest Diagnostics Inc. stock trades under the ticker DGX & has shown recent bullish behavior that traders & investors should research further into.
DGX stock closed at $146.28/share on 2/8/2023.
Quest Diagnostics Inc. DGX Stock’s Technical Performance Broken Down
DGX Stock Price: $146.28
10 Day Moving Average: $146.13
50 Day Moving Average: $149.53
200 Day Moving Average: $137.56
RSI: 46.95
MACD: -1.153
Yesterday, DGX stock completed a bullish MACD crossover, gaining 0.25% on the day’s session.
Recent trading volumes have been above average compared to the year prior & their RSI is neutral, but their recent candlesticks signal there may be near-term weakness for a more favorable entry-point.
DGX stock has support at the $146.19 & $143.58/share price levels, as they try to break out & above the $149.53 & $150.57/share resistance levels.
Quest Diagnostics Inc. DGX Stock As A Long-Term Investment
Long-term oriented investors will like DGX stock’s valuation metrics, with a 17.92 P/E (ttm) & a 2.69 P/B (mrq).
They recently reported -15% Quarterly Revenue Growth Y-o-Y, with -74.1% Quarterly Earnings Growth Y-o-Y, which investors will want to look closer into.
Their balance sheet will also require a more thorough review, with $315M of Total Cash (mrq) & $4.62B of Total Debt (mrq).
DGX stock pays a 1.81% dividend, which appears to be sustainable in the long-run, as their payout ratio is 24.84%.
97.7% of DGX stock’s outstanding share float is owned by institutional investors.
Quest Diagnostics Inc. DGX Stock As A Short-Term Trade Using Options
Traders with shorter time horizons can trade options to protect their portfolio from volatility, while profiting from movements in DGX stock’s price.
I am looking at the contracts with the 3/17 expiration date.
The $145, $135 & $140 call options are all in-the-money, listed from most to least levels of open interest.
The $150 puts are also in-the-money.
Tying It All Together
DGX stock has many interesting attributes that traders & investors are sure to find appealing.
Investors will like their dividend, as well as their valuation metrics, but will want to review their balance sheet & recent growth in more detail.
Traders will like their recent technical performance, but may wish their options were more liquid.
Overall, it is worth taking a closer look into DGX stock to see how it fits into your portfolio strategy.
*** I DO NOT OWN SHARES OR OPTIONS POSITIONS IN DCOM STOCK AT THE TIME OF PUBLISHING THIS ARTICLE ***